The company said net sales for Q4 2024 rose to $748.8 million, up 2.3%, and organic net sales grew 3.3%. Reported-diluted EPS for Q4 fell 2.7% to $1.78, and adjusted-diluted EPS fell 0.5% to $1.82.

1. 01

   The company said net sales for Q4 2024 rose to $748.8 million, up 2.3%, and organic net sales grew 3.3%. Reported-diluted EPS for Q4 fell 2.7% to $1.78, and adjusted-diluted EPS fell 0.5% to $1.82.

2. 02

   The company reported that net sales for 2024 fell to $2,893.2 million from $2,949.8 million, and gross profit margin declined to 34.5% from 38.3%. Net income for the year was $492.7 million, down from $593.4 million in the prior year.

3. 03

   The company said operating cash flow for 2024 fell 15.9% to $653.4 million, and capital expenditures rose 4.1% to $377.0 million. Free cash flow declined 33.3% to $276.4 million, and the company repurchased 1,583,032 shares for $560.9 million during the year.

4. 04

   The company outlined its outlook for net sales of $2.875 billion to $2.905 billion and adjusted-diluted EPS of $6.00 to $6.20 for 2025. The outlook includes a headwind of about $75 million in net sales and about $0.23 in EPS based on current foreign currency exchange rates, and the company expects capital spending of $275 million.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.